HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Modeling and Re-Engineering of Azotobacter vinelandii Alginate Lyase to Enhance Its Catalytic Efficiency for Accelerating Biofilm Degradation.

Abstract
Alginate is known to prevent elimination of Pseudomonas aeruginosa biofilms. Alginate lyase (AlgL) might therefore facilitate treatment of Pseudomonas aeruginosa-infected cystic fibrosis patients. However, the catalytic activity of wild-type AlgL is not sufficiently high. Therefore, molecular modeling and site-directed mutagenesis of AlgL might assist in enzyme engineering for therapeutic development. AlgL, isolated from Azotobacter vinelandii, catalyzes depolymerization of alginate via a β-elimination reaction. AlgL was modeled based on the crystal structure template of Sphingomonas AlgL species A1-III. Based on this computational analysis, AlgL was subjected to site-directed mutagenesis to improve its catalytic activity. The kcat/Km of the K194E mutant showed a nearly 5-fold increase against the acetylated alginate substrate, as compared to the wild-type. Double and triple mutants (K194E/K245D, K245D/K319A, K194E/K245D/E312D, and K194E/K245D/K319A) were also prepared. The most potent mutant was observed to be K194E/K245D/K319A, which has a 10-fold improved kcat value (against acetylated alginate) compared to the wild-type enzyme. The antibiofilm effect of both AlgL forms was identified in combination with piperacillin/tazobactam (PT) and the disruption effect was significantly higher in mutant AlgL combined with PT than wild-type AlgL. However, for both the wild-type and K194E/K245D/K319A mutant, the use of the AlgL enzyme alone did not show significant antibiofilm effect.
AuthorsChul Ho Jang, Yu Lan Piao, Xiaoqin Huang, Eun Jeong Yoon, So Hee Park, Kyoung Lee, Chang-Guo Zhan, Hoon Cho
JournalPloS one (PLoS One) Vol. 11 Issue 6 Pg. e0156197 ( 2016) ISSN: 1932-6203 [Electronic] United States
PMID27253324 (Publication Type: Journal Article)
Chemical References
  • Alginates
  • Anti-Bacterial Agents
  • Hexuronic Acids
  • Mutant Proteins
  • Penicillanic Acid
  • Glucuronic Acid
  • Polysaccharide-Lyases
  • poly(beta-D-mannuronate) lyase
  • Tazobactam
  • Piperacillin
Topics
  • Alginates (chemistry, metabolism)
  • Amino Acid Sequence (genetics)
  • Anti-Bacterial Agents (chemistry, pharmacology)
  • Azotobacter vinelandii (enzymology)
  • Biofilms (drug effects)
  • Catalysis
  • Glucuronic Acid (chemistry, metabolism)
  • Hexuronic Acids (chemistry, metabolism)
  • Mutagenesis, Site-Directed
  • Mutant Proteins (chemistry, genetics, pharmacology)
  • Penicillanic Acid (analogs & derivatives, pharmacology)
  • Piperacillin (pharmacology)
  • Polysaccharide-Lyases (chemistry, genetics, pharmacology)
  • Pseudomonas aeruginosa (drug effects)
  • Tazobactam

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: